脑转移患者立体定向放疗后的局部控制与毒性及新型全身治疗的影响
该回顾性连续队列研究纳入2018年6月至2020年5月期间在本机构就诊的262例脑转移患者,分析单纯放疗与放疗联合全身治疗对受照脑转移灶局部控制及毒性的影响。中位至局部失败时间为18个月(IQR 9-34),中位总生存期为20个月(IQR 10-36)。接受任何形式全身治疗的患者立体定向放射外科后局部控制更好。
要点
- 乳腺癌患者局部控制较差(HR 2.3,95%CI 1.0-5.0,p=0.038)。
- 未接受任何全身治疗的患者局部控制较差(HR 2.1,95%CI 1.1-4.3,p=0.034)。
- 症状性放射性坏死发生于36例(14%)患者,直径>2.5 cm与放射性坏死风险更高相关。
核心结论
- 接受任何形式全身治疗的患者在脑转移立体定向放射外科后局部控制更好。
- 未发现全身治疗与放射性坏死发生率之间的关联。
研究设计与样本
- 回顾性连续队列研究,纳入2018年6月至2020年5月期间在本机构就诊的脑转移患者,共262例连续治疗患者。
- 比较单纯放疗与放疗联合全身治疗对受照脑转移灶局部控制及毒性的影响;化疗和靶向治疗在放疗前后暂时停用。
主要发现
- 受照脑转移灶的中位至局部失败时间为18个月(IQR 9-34),中位总生存期为20个月(IQR 10-36)。
- 211例(81%)患者接受了全身治疗。
- 乳腺癌患者局部控制较差(HR 2.3,95%CI 1.0-5.0,p=0.038);未接受任何全身治疗的患者局部控制也较差(HR 2.1,95%CI 1.1-4.3,p=0.034)。
- 症状性放射性坏死发生于36例(14%)患者;直径>2.5 cm与放射性坏死风险更高相关。
- 未发现全身治疗联合局部放疗与症状性放射性坏死之间的关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Treatment modalities for patients with brain metastases consist of surgery, radiotherapy, and systemic treatments such as immunotherapy and targeted therapy. Although much is known about local control of brain metastases after radiotherapy and surgery alone, more understanding is needed of the additional effect of new systemic treatments. Our study presents real-world data about the combined effects of different local and systemic treatment strategies on local response of irradiated brain metastases. MATERIALS AND METHODS: We performed a retrospective consecutive cohort study of patients that presented with brain metastases in our institution between June 2018 and May 2020, reporting the impact of radiotherapy alone versus radiotherapy combined with systemic treatment on local control of irradiated brain metastases and toxicity. Chemotherapy and targeted therapy were temporarily discontinued around irradiation. RESULTS: 262 consecutively treated patients were included in the study. Median time to local failure of irradiated brain metastases was 18 months (IQR 9-34), median overall survival was 20 months (IQR 10-36). 211 (81 %) patients received systemic treatment. Patients with breast cancer had a worse local control (HR 2.3, 95 % CI 1.0-5.0, p = 0.038), as did patients without any systemic treatment (HR 2.1, 95 % CI 1.1-4.3, p = 0.034). Symptomatic radiation necrosis occurred in 36 (14 %) patients. A diameter > 2.5 cm was associated with a higher risk of radiation necrosis. No association was found between systemic treatment in combination with local radiotherapy and symptomatic radiation necrosis. CONCLUSION: Patients who received any form of systemic treatment had better local control after stereotactic radiosurgery for brain metastases. We did not find an association between systemic treatment and the incidence of radiation necrosis.
引用
- van Schie P, Huisman RG, Wiersma T, et al. Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments. Radiother Oncol. 2024. PMID: 39293720. doi:10.1016/j.radonc.2024.110540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。